From Medscape Diabetes & Endocrinology

Coverage from the

American Thyroid Association (ATA) 2023 Meeting

September 27 - October 01, 2023; Washington, DC

September 27 - October 01, 2023 Washington, DC

ATA 2023 Less Dairy Leads to Decline in Iodine Concentrations Iodine concentration declines among women of reproductive age in the United States over two decades correlate with reductions in dairy consumption.
Medscape Medical News, October 4, 2023

Conference News

ATA 2023 Nonsurgical Option for More Large Thyroid Nodule Patients?
Medscape Medical News, October 11, 2023
ATA 2023 Thyroid Cancer Increase Observed in Transgender Female Veterans
Medscape Medical News, October 5, 2023
ATA 2023 Less Dairy Leads to Decline in Iodine Concentrations
Medscape Medical News, October 4, 2023

ATA 2023 Hold Blood Thinners During Thyroid Nodule Biopsy?
Medscape Medical News, October 3, 2023
ATA 2023 Triple Therapy Boosts Anaplastic Thyroid Cancer Survival
Medscape Medical News, September 29, 2023

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News From ATA 2022

Stopping Levothyroxine in Subclinical Hypothyroidism Safe, Feasible Despite apparent lack of benefits, many still receive levothyroxine for subclinical hypothyroidism. Study helps fill a data gap on discontinuation.
Medscape Medical News, Oct 24, 2022
Don't Be Afraid of Weight Gain With Hyperthyroid Treatment A large study shows highest weight gain risk is with thyroidectomy, and radioiodine therapy is linked to better survival.
Medscape Medical News, Oct 21, 2022
Thyroid Nodule Volume Reduction Correlates With Energy in Ablation Higher increases in radiofrequency energy strongly improve odds of achieving a greater than 50% reduction in nodule size.
Medscape Medical News, Nov 02, 2022

Previous Coverage